Lee Shoa Long Clarke, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 4 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Clarke’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A149702 · Current
Licensed to practise in California · since 2017 · expires 2028-11-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$17,904
Medicare paid this office $17,904 for 287 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,686 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,455 | $117 |
| Return visit (30+ min) | 20 | $1,891 | $86 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,889 | $105 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $1,834 | $73 |
See all 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,686 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,455 | $117 |
| Return visit (30+ min) | 20 | $1,891 | $86 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,889 | $105 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $1,834 | $73 |
| Return visit (30+ min) | 13 | $1,617 | $116 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 163 | $1,220 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 21 | $479 | $23 |
Who their Medicare patients are
287 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 20% · Women 45% · Also on Medicaid 31% · Health risk score 2.40. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 55% · Atrial fibrillation 49% · Heart failure 45% · Chronic kidney disease 44% · Diabetes 36% · Depression 32% · Cancer 22% · COPD 20% · Stroke 20% · Dementia 19%.
The office billed $86,352, Medicare allowed $22,860 and paid $17,904; for 381 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 287 | 381 | 75 | 2.40 | $86,352 | $17,904 |
| 2023 | 188 | 252 | 75 | 2.16 | $66,875 | $14,193 |
| 2022 | 125 | 232 | 73 | 2.10 | $87,908 | $20,107 |
| 2021 | 126 | 230 | 75 | 2.25 | $80,522 | $18,107 |
| 2020 | 25 | 42 | 76 | 1.59 | $19,884 | $4,277 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,137 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,511 | $120 |
| Return visit (30+ min) | 28 | $2,502 | $83 |
| Hospital discharge day management, more than 30 minutes | 21 | $2,249 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 90 | $688 | $7 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $383 | $23 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $4,498 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,201 | $119 |
| Return visit (30+ min) | 28 | $2,861 | $87 |
| Hospital discharge day management, more than 30 minutes | 24 | $2,417 | $97 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $2,257 | $87 |
| Hospital observation care on day of discharge | 11 | $719 | $65 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $7,088 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $2,232 | $124 |
| Long return visit (40+ min) | 11 | $1,800 | $129 |
| Return visit (30+ min) | 20 | $1,667 | $79 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $700 | $35 |
Medicaid work
$1,467 in 2024
Medicaid paid $1,467 for 141 billed services this clinician did in 2024, up to 126 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 141 | $1,467 |
| 2024 | 141 | 1 | 126 | $1,467 |
| 2023 | 93 | 2 | 76 | $1,233 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 80 | $782 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 13 | $451 |
Drugs they prescribed that Part D paid
$84,648
Pharmacies billed $84,648 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 363) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
285 generic and 78 brand-name prescriptions · $84,648 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Repatha Sureclick | 19 | $13,470 | $709 |
| Praluent | 12 | $12,522 | $1,044 |
| Rosuvastatin | 46 | $797 | $17 |
| Ezetimibe | 28 | $713 | $25 |
| Metoprolol | 35 | $592 | $17 |
See all 10 drugs
| Repatha Sureclick | 19 | $13,470 | $709 |
| Praluent | 12 | $12,522 | $1,044 |
| Rosuvastatin | 46 | $797 | $17 |
| Ezetimibe | 28 | $713 | $25 |
| Metoprolol | 35 | $592 | $17 |
| Atorvastatin | 35 | $290 | $8 |
| Clopidogrel | 15 | $225 | $15 |
| Losartan | 27 | $187 | $7 |
| Amlodipine Besylate | 15 | $21 | $1 |
| Metoprolol | 12 | $8 | $1 |
Year by year
| 2024 | 363 | 59 | 0% (0) | 21% | $84,648 |
| 2023 | 315 | 53 | 0% (0) | 17% | $63,153 |
| 2022 | 271 | 50 | 0% (0) | None | $46,060 |
| 2021 | 177 | 37 | 0% (0) | 17% | $30,797 |
| 2020 | 22 | None | 0% (0) | None | $3,121 |
| 2018 | 15 | None | 0% (0) | None | $352 |
| 2017 | 100 | 16 | None | None | $15,372 |
| 2016 | 202 | 29 | 0% (0) | None | $25,834 |
| 2015 | 214 | 23 | 0% (0) | 27% | $31,842 |
| 2014 | 170 | 31 | 7% (11) | 26% | $15,011 |
| 2013 | 74 | 18 | None | None | $3,124 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Repatha Sureclick | 20 | $12,013 | $601 |
| Rosuvastatin | 48 | $1,897 | $40 |
| Metoprolol | 31 | $696 | $22 |
| Ezetimibe | 15 | $674 | $45 |
| Atorvastatin | 39 | $518 | $13 |
| Losartan | 21 | $420 | $20 |
| Clopidogrel | 15 | $198 | $13 |
| Hydrochlorothiazide | 11 | $22 | $2 |
2022: 8 drugs
| Repatha Sureclick | 21 | $11,505 | $548 |
| Rosuvastatin | 43 | $1,585 | $37 |
| Ezetimibe | 20 | $710 | $35 |
| Atorvastatin | 34 | $506 | $15 |
| Metoprolol | 26 | $429 | $17 |
| Losartan | 18 | $241 | $13 |
| Amlodipine Besylate | 12 | $200 | $17 |
| Clopidogrel | 14 | $79 | $6 |
2021: 4 drugs
| Ezetimibe | 20 | $654 | $33 |
| Rosuvastatin | 25 | $560 | $22 |
| Metoprolol | 26 | $456 | $18 |
| Atorvastatin | 17 | $304 | $18 |
2017: 1 drug
| Atorvastatin | 11 | $223 | $20 |
2016: 5 drugs
| Atorvastatin | 11 | $235 | $21 |
| Metoprolol | 11 | $223 | $20 |
| Metformin | 18 | $183 | $10 |
| Amlodipine Besylate | 13 | $108 | $8 |
| Lisinopril | 11 | $86 | $8 |
2015: 6 drugs
| Xarelto | 13 | $4,881 | $375 |
| Omeprazole | 18 | $148 | $8 |
| Lisinopril | 14 | $108 | $8 |
| Metformin | 12 | $77 | $6 |
| Metoprolol | 11 | $68 | $6 |
| Gabapentin | 11 | $67 | $6 |
2014: 2 drugs
| Omeprazole | 12 | $103 | $9 |
| Metformin | 13 | $79 | $6 |
Money from drug and device companies
$26 in 2025
| 2025 | 1 | 1 | None | $26 |
| 2024 | 1 | 1 | None | $27 |
| 2023 | 1 | 1 | None | $120 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Merck Sharp & Dohme | None | $26 | 1 payment
|
See the published payment
| Merck Sharp & Dohme | Education · 2025-11-10 | None | $26 |
See earlier years (2024, 2023)
2024: $27
| Amgen | Otezla | $27 | 1 payment
|
2023: $120
| Amgen | Otezla | $120 | 1 payment
|
Professional record
- NPI
- 1639517030
- Licence
- CA A149702, MA 255588California A149702: Current · expires 2028-11-30
- Trained
- Stanford University School of Medicine, 2013
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X); Pediatrics (208000000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-06-06
- NPI last updated
- 2024-04-20
- NPI record certified
- 2024-04-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 75 Francis St, Boston, MA, 02115